Weiming Li

Weiming Li currently serves as Vice President of Strategy, Portfolio, and Business Development at Fresenius Kabi, overseeing corporate strategy for Fresenius Kabi China and its five subsidiaries. Previous experience includes serving as Country General Manager for Rx and OTC business at Pierre Fabre Group, and Director of Strategic Planning and Business Development at B. Braun Medical. Li has also held roles at Novartis, including Director of Strategic Planning, Business Development & Licensing, and at Janssen Pharmaceutical Companies of Johnson & Johnson as Regional Sales Manager/National SFE Manager. Educational achievements include an MBA in General Management from Rotterdam School of Management and participation in leadership development programs at Johnson & Johnson and Harvard Business School.